Scientists laid out the framework for a new COVID-19 drug design that blocks the virus from replicating and disabling human proteins crucial to the immune response.

The discovery is expected to be a springboard for future development of novel drugs to treat cardiovascular disease, metabolic disorders such as diabetes and other diseases.

Mingjiang Xu, MD, PhD, professor of molecular medicine, was awarded a $1 million UT System Faculty STARs award to enhance cancer epigenetics research and support the discovery of targeted therapeutics for blood cancers.

New reports from Salud America! at UT Health San Antonio investigate the failure of investing in project-by-project transportation projects, and recommend systemic changes to reverse unfair planning practices that overlook Latino communities.

A new study implicates 160 genes in brain shrinkage seen on MRIs of 45,000 healthy adults. The shrinkage is in the cortex, the dimply outer layer of the brain that gives rise to thinking, awareness and action, and largely consists of gray matter.